News archive

Thierry Diagana, California Sites Head at Novartis, shares the vision for a new research hub that will power future drug discovery.

Maurice W.*, a Medical Science Liaison at Novartis, was shocked to learn he had elevated Lp(a), an inherited risk factor for heart disease.^1,2

At Aspen Ideas Health, Novartis is leading conversations about how to address today’s most pressing healthcare concerns. Learn how we’re launching bold awareness campaigns and unique community partnerships—meeting patients where they are to drive change.

Katy Shusta is helping to rewrite the narrative around hidradenitis suppurativa (HS) – a painful skin condition impacting as many as one in 100 people worldwide.¹  

Learn about the launch of our new state-of-the-art space, built to accelerate innovation from the inside out and provide new solutions for employees, partners and ultimately, our patients.

Elevated Lp(a) is a unique and genetically determined condition that can increase risk for ASCVD¹.  Read on to learn more about patient populations at risk.